Vericel Corp at UBS Global Healthcare Conference Transcript
Okay. Thanks, everybody, for joining us. For our next session, we're joined by management from Vericel. So behind me is Nick Colangelo, who is the President and CEO. And he's going to go through a slide presentation. And if we have any time at the end, we'll do a little bit of Q&A, but we're going to have a breakout downstairs.
So let me turn it over to you, Nick. Take it away.
Okay. Well, thanks. It's great to be here for the first time at the UBS conference. So we appreciate the invitation.
So before I begin, I'd like to remind you that this presentation contains forward-looking statements. Hence, you should refer to our documents on file with the SEC for further information.
So Vericel is a leader in advanced therapies for the sports medicine and severe burn care markets. We have a highly innovative, advanced cell therapy platform, and our strategy has been to build our commercial franchises around our cell therapy products in our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |